These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6128846)

  • 1. [Prognosis of the effectiveness of pharmacotherapy of patients with acute schizophrenia based on a correlation and regression analysis of clinical and electroencephalographic indices].
    Nemtsov AV; Kalinin VV; Zaĭtsev SG; Golikova TI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982 Sep; 82(9):68-73. PubMed ID: 6128846
    [No Abstract]   [Full Text] [Related]  

  • 2. [Depressive symptoms in schizophrenia].
    Gerard A
    Encephale; 1998 Jul; 24 Spec No 1():24-6. PubMed ID: 9809250
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of treating early-onset malignant schizophrenia with psychotropic drugs and their combinations].
    Sobolev ES; Zaĭtsev SG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(1):114-21. PubMed ID: 6111878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.
    Itil TM; Polvan N; Ucok A; Eper E; Güven F; Hsu W
    Behav Neuropsychiatry; 1971 Dec; 3(9):6-13. PubMed ID: 4948869
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of neuroleptics on depressive symptoms].
    Tabeze JP
    Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254
    [No Abstract]   [Full Text] [Related]  

  • 6. Issues in polypharmacotherapy: focus on depression in schizophrenia.
    Dufresne RL
    Psychopharmacol Bull; 1995; 31(4):789-96. PubMed ID: 8851655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimethodological approach in psychiatric predictor research.
    Woggon B; Baumann U
    Pharmacopsychiatria; 1983 Nov; 16(6):175-8. PubMed ID: 6141574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Depressive patients with delusions--diagnosis and pharmacotherapy in a difficult group with depression].
    Wolfersdorf M; König F
    Schweiz Rundsch Med Prax; 1994 Apr; 83(15):438-43. PubMed ID: 7910412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Maintenance and termination of drug therapy in psychiatry].
    Watanabe M
    Seishin Shinkeigaku Zasshi; 1999; 101(12):1018-23. PubMed ID: 10810606
    [No Abstract]   [Full Text] [Related]  

  • 10. Implementation of a rational pharmacotherapy intervention for inpatients at a psychiatric department.
    Sorensen L; Nielsen B; Stage KB; Brøsen K; Damkier P
    Nord J Psychiatry; 2008; 62(3):242-9. PubMed ID: 18622885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of psychotropic drug prescription in four midwestern state hospitals.
    Altman H; Evenson RC; Sletten IW; Cho DW
    Curr Ther Res Clin Exp; 1972 Oct; 14(10):667-72. PubMed ID: 4404476
    [No Abstract]   [Full Text] [Related]  

  • 12. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.
    Raskin S; Katz G; Zislin Z; Knobler HY; Durst R
    Acta Psychiatr Scand; 2000 Apr; 101(4):334-6. PubMed ID: 10782556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regression analysis of clinical data for purposes of predicting the efficacy of psychopharmacotherapy of episodes of schizophrenia].
    Zaĭtsev SG; Kalinin VV; Golikova TI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(1):91-7. PubMed ID: 3953201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polypharmacy in the treatment of schizophrenia].
    Messer T; Tiltscher C; Schmauss M
    Fortschr Neurol Psychiatr; 2006 Jul; 74(7):377-91. PubMed ID: 16804806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation and management of patients with first-episode schizophrenia: a selective, clinical review of diagnosis, treatment, and prognosis.
    Freudenreich O; Holt DJ; Cather C; Goff DC
    Harv Rev Psychiatry; 2007; 15(5):189-211. PubMed ID: 17924256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of treatment effects in schizophrenia.
    Stroup TS
    Am J Med; 2007 Apr; 120(4 Suppl 1):S26-31. PubMed ID: 17403379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological standards in schizophrenia treatment].
    Jarema M; Kiejna A; Landowski J; Meder J; Jolanta RJ; Rybakowski J
    Psychiatr Pol; 2006; 40(6):1171-205. PubMed ID: 17444297
    [No Abstract]   [Full Text] [Related]  

  • 18. Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine.
    Bender S; Olbrich HM; Fischer W; Hornstein C; Schoene W; Falkai P; Haarmann C; Berger M; Gastpar M;
    Pharmacopsychiatry; 2003; 36(2):61-9. PubMed ID: 12734763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
    Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H
    Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial].
    Shiloh R; Weizman A; Weizer N; Dorfman-Etrog P; Munitz H
    Harefuah; 2001 May; 140(5):369-73, 456. PubMed ID: 11419053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.